SIFI’s AKANTIOR gains EC approval for acanthamoeba keratitis
Italian ophthalmic company SIFI has received European Commission (EC) approval for AKANTIOR (polihexanide) to treat acanthamoeba keratitis (AK), a rare…
Italian ophthalmic company SIFI has received European Commission (EC) approval for AKANTIOR (polihexanide) to treat acanthamoeba keratitis (AK), a rare…
The US Food and Drug Administration (FDA) has approved Sandoz’s Enzeevu (aflibercept-abzv), the drugmaker’s biosimilar for wet age-related macular degeneration…
Taiwan-based Formosa Pharmaceuticals has signed an exclusive licensing agreement with Apotex to commercialise clobetasol propionate ophthalmic suspension 0.05% (APP13007), for…
The European Commission (EC) has approved Roche’s Vabysmo (faricimab) for the treatment of retinal vein occlusion, adding a third indication…
Two months after MSD (Merck & Co) set its eye on acquiring Eyebiotech (EyeBio), the former has closed the deal,…
Two years following a voluntary recall, Roche has relaunched Susvimo (ranibizumab injection) for use as an ocular implant for the…
Roche has received approval from the US Food and Drug Administration (FDA) for the Vabysmo (faricimab) 6.0mg single-dose prefilled syringe…
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has backed approval for Akantior (polihexanide), a…
MSD has announced a definitive agreement to acquire all outstanding shares of Eyebiotech (EyeBio) through a subsidiary for up to…
Turn Biotechnologies (Turn Bio) has entered an exclusive worldwide licensing agreement with HanAll Biopharma to develop therapies for age-related eye…